These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33406924)

  • 1. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
    Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
    Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy Increases aMMP-8-Levels and Neutrophil/Lymphocyte Ratio Rapidly in Head and Neck Cancer Patients: A Pilot Study.
    Brandt E; Keskin M; Tervahartiala T; Yılmaz M; Harmankaya İ; Karaçetin D; İpek T; Gürsoy UK; Rautava J; Gupta S; Hagström J; Räisänen IT; Sorsa T
    Cancer Control; 2023; 30():10732748231163653. PubMed ID: 37092545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of Collagenolytic MMP-8 and -9 Tissue Destruction Cascade in Mouth by Head and Neck Cancer Radiotherapy: A Cohort Study.
    Brandt E; Keskin M; Räisänen IT; Tervahartiala T; Mäkitie A; Harmankaya İ; Karaçetin D; Hagström J; Rautava J; Sorsa T
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
    Keles Yucel ZP; Afacan B; Emingil G; Tervahartiala T; Kose T; Sorsa T
    J Periodontal Res; 2020 Dec; 55(6):887-894. PubMed ID: 32790178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
    Deng K; Pelekos G; Jin L; Tonetti MS
    J Clin Periodontol; 2021 Aug; 48(8):1051-1065. PubMed ID: 33998040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
    Noack B; Kipping T; Tervahartiala T; Sorsa T; Hoffmann T; Lorenz K
    J Periodontal Res; 2017 Oct; 52(5):824-831. PubMed ID: 28345244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability of an active matrix metalloproteinase-8 point-of-care test in an oral and maxillofacial surgery clinic: a pilot study.
    Kallio E; Puolakkainen T; Tervahartiala T; Snäll J; Marttila E; Sorsa T; Uittamo J
    Odontology; 2024 Jan; 112(1):250-255. PubMed ID: 37249720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated matrix metalloproteinase-8 in saliva as diagnostic test for periodontal disease? A case-control study.
    Izadi Borujeni S; Mayer M; Eickholz P
    Med Microbiol Immunol; 2015 Dec; 204(6):665-72. PubMed ID: 25841875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active Matrix Metalloproteinase-8 (aMMP-8) Versus Total MMP-8 in Periodontal and Peri-Implant Disease Point-of-Care Diagnostics.
    Räisänen IT; Aji NRAS; Sakellari D; Grigoriadis A; Rantala I; Pätilä T; Heikkilä P; Gupta S; Sorsa T
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vivo Regulation of Active Matrix Metalloproteinase-8 (aMMP-8) in Periodontitis: From Transcriptomics to Real-Time Online Diagnostics and Treatment Monitoring.
    Aji NRAS; Yucel-Lindberg T; Räisänen IT; Kuula H; Nieminen MT; Mc Crudden MTC; Listyarifah D; Lundmark A; Lundy FT; Gupta S; Sorsa T
    Diagnostics (Basel); 2024 May; 14(10):. PubMed ID: 38786309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the diagnostic discrimination ability of mouthrinse and salivary aMMP-8 point-of-care testing regarding periodontal health and disease.
    Räisänen IT; Heikkinen AM; Nwhator SO; Umeizudike KA; Tervahartiala T; Sorsa T
    Diagn Microbiol Infect Dis; 2019 Dec; 95(4):114871. PubMed ID: 31473032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accuracy of aMMP-8 point-of-care test in indicating periodontal treatment outcomes in stage III/IV periodontitis: A 24-week follow-up study.
    Yilmaz M; Sorsa T; Demir E; Gürsoy M; Suominen A; Tervahartiala T; Räisänen IT; Gürsoy UK
    J Periodontal Res; 2023 Apr; 58(2):325-335. PubMed ID: 36618000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A point-of-care test of active matrix metalloproteinase-8 predicts triggering receptor expressed on myeloid cells-1 (TREM-1) levels in saliva.
    Räisänen IT; Heikkinen AM; Pakbaznejad Esmaeili E; Tervahartiala T; Pajukanta R; Silbereisen A; Bostanci N; Sorsa T
    J Periodontol; 2020 Jan; 91(1):102-109. PubMed ID: 31343739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
    Yuan C; Liu X; Zheng S
    BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active matrix metalloproteinase-8 and periodontal bacteria-interlink between periodontitis and inflammatory bowel disease?
    Schmidt J; Weigert M; Leuschner C; Hartmann H; Raddatz D; Haak R; Mausberg RF; Kottmann T; Schmalz G; Ziebolz D
    J Periodontol; 2018 Jun; 89(6):699-707. PubMed ID: 29574823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.